How should uremia be managed in patients with aortic dissection?

Management of Uremia in Patients with Aortic Dissection

In patients with aortic dissection who develop uremia, prioritize immediate aggressive blood pressure and heart rate control while urgently evaluating for renal malperfusion that may require intervention before or concurrent with definitive aortic repair, particularly in Type A dissections with mesenteric or renal ischemia.

Initial Hemodynamic Management Takes Priority

Regardless of uremia presence, all patients with acute aortic dissection require immediate anti-impulse therapy 1. Target systolic blood pressure <120 mmHg (or lowest BP maintaining end-organ perfusion) and heart rate 60-80 bpm 1. This is accomplished through:

• Intravenous beta-blockers first (esmolol, metoprolol, or labetalol) 2, 1
• Add IV vasodilators (nicardipine, clevidipine, or nitroprusside) only after achieving rate control 2, 1
• Use non-dihydropyridine calcium channel blockers (verapamil or diltiazem) if beta-blockers are contraindicated 2

Critical pitfall: Never initiate vasodilators before rate control, as reflex tachycardia increases aortic wall stress and propagates dissection 2.

Determine the Cause of Uremia

The presence of uremia in aortic dissection typically indicates one of three scenarios:

1. Pre-existing end-stage renal disease (ESRD) - Present in approximately 20% of aortic dissection patients 3, 4
2. Acute kidney injury from renal malperfusion - Occurs when dissection involves renal arteries (5-10% of cases) 3, 5
3. Acute kidney injury from hypoperfusion - Related to hemodynamic instability

Management Algorithm Based on Dissection Type and Renal Status

Type A Dissection (Ascending Aorta)

Proceed to emergent surgical repair regardless of uremia 2. Type A dissections require urgent surgery due to high rupture risk 2. The presence of uremia does not change this indication.

If clinical evidence of mesenteric or renal ischemia exists:

• Some centers advocate endovascular reperfusion strategies (fenestration or branch stenting) before central aortic repair 1
• Other centers proceed directly to central aortic repair first 1
• Data are limited to define the optimal strategy, but surgical/hybrid approaches show superior outcomes to medical therapy alone 1

Perioperative considerations:

• Acute kidney injury requiring dialysis occurs in 24.6% of Type A dissection patients postoperatively 3
• Patients with pre-existing ESRD have similar in-hospital mortality to those without ESRD 4
• Continuous veno-venous hemodialysis can be initiated perioperatively, transitioning to intermittent hemodialysis as clinically appropriate 6

Type B Dissection (Descending Aorta)

Complicated Type B dissection (with malperfusion, progression, rupture, or uncontrolled BP):

• Emergency intervention is required 2, 7
• TEVAR is first-line therapy 7
• If renal malperfusion is present, endovascular fenestration or branch stenting may be necessary 1

Uncomplicated Type B dissection:

• Manage medically with aggressive BP control 2, 7
• Consider TEVAR in subacute phase (14-90 days) if high-risk features present 7
• Acute kidney injury occurs in 8.2% requiring dialysis 3

Specific Considerations for ESRD Patients

Patients with pre-existing ESRD presenting with aortic dissection have distinct characteristics 4:

• More likely to have atypical presentations without classic chest pain 4, 6
• Higher prevalence of Type B dissections and hypertension 4
• More commonly managed medically rather than surgically 4
• Similar in-hospital mortality compared to non-ESRD patients 4

For peritoneal dialysis patients:

• Temporarily switch to hemodialysis perioperatively 6
• Can transition back to peritoneal dialysis approximately 6 weeks post-surgery 6

Renal Replacement Therapy Decisions

Initiate dialysis for standard uremic indications:

• Severe metabolic acidosis
• Hyperkalemia refractory to medical management
• Volume overload compromising hemodynamic goals
• Uremic symptoms (pericarditis, encephalopathy)

Timing considerations:

• For Type A dissections: Do not delay surgery for dialysis; can initiate continuous renal replacement therapy intraoperatively or immediately postoperatively
• For Type B dissections managed medically: Standard dialysis timing applies
• Preoperative peritoneal dialysis has been successfully used in select cases before TEVAR 8

Blood Pressure Management in Uremic Patients

The BP target remains <120 mmHg systolic 1, 9, even in patients with ESRD. This supersedes typical concerns about maintaining higher BP in dialysis patients. The immediate threat of aortic rupture or propagation takes precedence over chronic kidney disease considerations.

Avoid NSAIDs (including ketorolac) for pain control due to risk of inducing hypertension and adverse renal effects 1. Use IV opiates instead 1.

Monitoring and Follow-up

• Arterial line monitoring in ICU setting is mandatory 1
• Serial creatinine and electrolyte monitoring
• Patients with partially occluded renal arteries may have impaired single-kidney function even without elevated serum creatinine 10
• Long-term antihypertensive therapy is essential for all survivors 7

The key principle is that uremia does not alter the fundamental management strategy for aortic dissection—hemodynamic control and appropriate surgical/endovascular intervention based on dissection type and complications remain paramount for survival.